
Hong Kong warned of surge in inflammatory bowel disease rates
Scientists from the study that was co-led by researchers from Hong Kong and Canada raised the alarm after a projection model estimated that the prevalence of inflammatory bowel disease in the city would rise from 40 cases per 100,000 people in 2014 to 100 in 2034.
'The 150 per cent increase in the total number in terms of prevalence – this is quite scary,' said Professor Ng Siew Chien, associate dean of the Chinese University of Hong Kong's medical school and an expert in gastroenterology who co-led the study.
Do you have questions about the biggest topics and trends from around the world? Get the answers with SCMP Knowledge, our new platform of curated content with explainers, FAQs, analyses and infographics brought to you by our award-winning team.
'We call this probably an explosion.'
Researchers found that the rates were related to economic development and that less developed places, such as Malaysia and mainland China, had lower rates than Hong Kong, although they were also trending upwards.
IBD refers to a group of conditions that cause swelling and inflammation of tissue in the digestive tract, with Crohn's disease and ulcerative colitis being the two most common types.
Common symptoms of such conditions include diarrhoea, abdominal pains and cramps, and blood in the stool. IBD sufferers are also more likely to develop serious illnesses such as colon cancer.
The researchers' projection model is based on real-world data collected from more than 500 studies in 82 regions that took place between 1920 and 2024.
It also anticipated a rise in the local incidence rate for IBD, which involves the number of new cases per 100,000 people.
While the rate in Hong Kong was 0.1 in 1985, it rose to about three in 2013 and is estimated to have exceeded four in 2023.
The figures placed the city in the second part of a four-stage model outlined in the study, meaning it was experiencing a phase of 'acceleration in incidence' in IBD cases.
Other jurisdictions that were seeing similar trends to Hong Kong included many relatively newly industrialised nations in Asia and Latin America, such as mainland China, Japan and South Korea.
In the mainland, the rate of new cases rose from two per 100,000 people in 2010, to 15 in 2020. The total number of IBD patients in the country is expected to exceed 1.5 million by this year, according to Ng.
The study, which was published in top scientific journal Nature last month, placed countries with low incidence and prevalence rates, such as many places in Africa, in the stage one category.
Most countries in North America, Europe and Oceania were classified as being in stage three, meaning the number of new cases had already slowed down, but the total number of patients had steadily increased.
While such conditions are not fatal and can be managed with medications and treatments, they cannot be cured. Serious cases can require surgery to remove a patient's colon and rectum, who must then carry a pouch to collect their waste.
The late Shinzo Abe resigned as the prime minister of Japan in 2020 due to his struggles with ulcerative colitis.
Study co-leader Professor Gilaad Kaplan, a gastroenterologist from the medical school of Canada's University of Calgary, said increases in new cases of IBD correlated with economic advancement.
'The earlier a country transitions into economic advancements, the earlier we see that trigger into stage two,' he said.
Kaplan said that while higher incidence and prevalence rates were due to improved detection and diagnostic tools in economically advanced regions, environmental factors also played a crucial role.
A person's diet was one of the strongest pillars under the category of environmental factors that contributed to a rise in cases, Kaplan and Ng said.
Diets that were high in fat, sugar, ultra-processed foods, additives and colourings could change the health of a person's gut, she said.
'These foods actually affect our gut microbiome, which is the bacteria and viruses inside our gut,' the researcher said.
'They can induce [and] increase bacteria that can cause inflammation ... These bacteria produce toxins and chemicals inside the gut, and then it makes the gut very thin.'
Ng explained that the resulting toxins and inflammatory responses inside the gut could then disturb one's immune system.
She added that a growing number of IBD patients could see the local healthcare system face an increased economic burden, citing her own separate analysis on the topic.
The academic noted that the average medical cost for a patient with the condition was about HK$40,000 to HK$50,000 (US$6,380) a year, about twice the amount paid by someone suffering from type 2 diabetes.
Kaplan, meanwhile, said that IBD patients would get older and become more challenging to manage if they developed other conditions such as diabetes or dementia.
Both researchers called for preventive actions to slow down IBD's growing prevalence and incidence rates.
'Our models show that if we can prevent the incidence of new diagnoses, even just by a small amount, that has a huge impact on blunting the overall growth or prevalence of the disease,' Kaplan said.
He added that people could stave off such conditions by adopting a healthy, whole food diet, while officials could create policies that increased the availability of healthy foods.
Sharing her tips on preventing the condition among the children of IBD patients, Ng said: 'Less processed food; just cook everything from scratch. Try not to use so many antibiotics if you can, because that changes the gut microbiome as well.'
More from South China Morning Post:
For the latest news from the South China Morning Post download our mobile app. Copyright 2025.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
3 days ago
- The Star
Cancer's secret weapon to evade death
Fat isn't just a guilty pleasure – it is cancer's secret weapon. New research from UT Southwestern Medical Center in the United States is shedding light on why this is the case. In a study published this month (July 2025) in the journal Nature , the researchers found that cancer cells steal fat-packed molecules from the bloodstream, allowing them to arm themselves with a potent antioxidant that shields them from death. Tumours appear to do this by reeling in lipoproteins – mole-cules that carry fats and fat-soluble nutrients like vitamin E in the bloodstream – through sugar-coated molecules on their cell surface. These sulphated glycosaminoglycans (GAGs) allow cancer cells to fortify their cell membranes with vitamin E and avoid a form of cell death called ferroptosis. Though clinical applications are still a way off, the study underscores how understanding cancer's metabolism could open new doors for treatment, said Northwestern University's Feinberg School of Medicine associate professor of urology Dr Shad Thaxton, who was not involved in the study. 'I think this paper and others in the field (emphasise) the appreciation for ferroptosis as a mechanism to kill cancer cells – that mechanism of cell death is so intimately intertwined with cell metabolism,' he said. 'I think what's interesting for people is that metabolism has a really big impact on the potential vulnerability of cancer cells to specific therapies.' Why cancer cells need fat Cancers rewire their metabolism in ways that support their growing horde of destructive cells. Some of this rewiring involves producing energy from glucose and acquiring cellular building blocks such as nucleic acids, proteins and lipids. Amassing cellular building blocks is especially crucial since a tumour's uncontrolled growth lends to it creating a hostile microenvironment where there aren't enough nutrients and other resources, said UT Southwestern Medical Center's Children's Medical Center Research Institute assistant professor Dr Javier Garcia-Bermudez, who led the study. Lipids are essential for a tumour to grow and progress. The plasma membrane of each cell is a bilayer of lipids; as cancer cells swell in number, they have to source lipids from their immediate environment or make their own to maintain their plasma membranes. Asst Prof Garcia-Bermudez said that was the prevailing theory as to why lipids are so important to cancer. Emerging research has since discovered that lipids may offer cancer cells more functional perks. For example, a September 2024 study found that cancer cells use a type of lipid called sphingolipid to go into stealth mode, thus evading detection and destruction by the immune system. Studies have also found lipids are somehow involved in ferroptosis, a type of cell death discovered in 2012. A portmanteau of 'ferrous', the Latin word for iron, and apoptosis, the scientific word for programmed cell death, ferroptosis happens when a build-up of toxic molecules called oxidants and iron overwhelms a cell, causing it to essentially rust from the inside out. 'Oxidants damage the lipids that are forming the membranes (of) a cell,' Asst Prof Garcia-Bermudez said. 'What's interesting is that cancer cells tend to produce more oxidants than normal cells,' he added, noting that there's been interest in understanding why some cancers are more susceptible to this type of damage and in using ferroptosis to kill cancer cells. GAG-ging cancer cells The crafty masters of survival that they are, cancer cells have devised ways to dodge ferroptosis. Unraveling the reason why put Asst Prof Garcia-Bermudez and his lab on a four-year journey of scientific inquiry. One of the researchers' first findings, after screening 200 metabolic genes linked to cancer, was that an enzyme called glutathione peroxidase 4 was active in tumours. This wasn't a new discovery: Studies have shown that this enzyme, which can stop lipids from degrading, plays a pivotal role in controlling ferroptosis. When glutathione peroxidase 4 was erased from a cancer cell's genome, the tumour would die, unless it was given a drug blocking ferroptosis or fed lipoproteins. 'That was a clue that lipoproteins were somehow related to ferroptosis,' said study co-author and UT Southwestern Medical Center's Eugene McDermott Center for Human Growth and Development director Prof Dr Ralph DeBerardinis. In a battery of experiments that included depriving cancer cells in petri dishes of lipoproteins and exposing them to different antioxidants, the full picture began to be unveiled. Cancer cells were intercepting lipoproteins – particularly those bearing vitamin E, a fat-soluble antioxidant – from their surrounding environment. Like a fisherman with a fishing line, cancer cells accomplished this not with the usual reels used to catch lipoproteins, but with the long, flowy sugar chains known as GAGs. These molecules are attached to a cancer cell surface through another molecule called a proteoglycan. When the scientists blocked the biochemical pathway responsible for manufacturing GAGs, this limited a lab-grown cancer cell's access to vitamin E and made it more vulnerable to ferroptosis. In mice grafted with cancer cells, cutting off the pathway slowed tumour growth. The researchers also examined 20 tumours donated by patients with clear cell renal carcinoma, the most common type of kidney cancer. These tumours had higher levels of GAGs and vitamin E – about 15 times more of the latter – compared to normal kidney tissue. Disrupting the biochemical pathway producing GAGs prevented kidney cancer cells from devouring vitamin E-laden lipoproteins, resulting in them dying by the iron hand of ferroptosis. Much more to be done Asst Prof Garcia-Bermudez and Prof DeBerardinis caution that there is much more research to be done before their study's findings have any clinical application for treating cancer. 'We know that GAGS are on the surface, they speak to the lipoproteins and they affect the uptake of lipoproteins,' Asst Prof Garcia-Bermudez said. 'But how mechanistically this happens, especially in the cancer cell, hasn't been shown before. 'If we understand how this works and we find molecular targets that maybe we can treat with drugs and block, then we have a way to specifically deplete vitamin E in the tumour.' Prof DeBerardinis said that the research does not suggest any association between dietary vitamin E and cancer risk, or how vitamin E levels correlate with cancer patient outcomes. Figuring out those possible connections would be points for future study. In the short term, he said, these findings could be used to investigate whether tumours with higher levels of GAGs or stored vitamin E are linked to patient outcomes, such as survival rates or how well they respond to treatment. Assoc Prof Thaxton said that there are currently no federally-approved cancer treatments in the US that incite ferroptosis. His lab is conducting research into synthetic lipoproteins devoid of any lipid passengers – a Trojan horse without soldiers hiding inside. The cancer cells expect to get the lipoproteins with fats like cholesterol and vitamin E, he said, but 'they end up dying of ferroptosis'. 'Our drug doesn't carry anything and it's through this mechanism by which you can kill the cell.' For Asst Prof Garcia-Bermudez and Prof DeBerardinis, their research efforts were like finding a needle in a haystack – one they hope to find more needles in. 'Our study is really exciting, but at the same time, it's a very basic discovery,' Asst Prof Garcia-Bermudez said. 'It was incredible to discover something that people have not observed in cancer before, to understand why these tumours are so resistant. I'm super excited to keep working on this.' – By Miriam Fauzia/The Dallas Morning News/tca/dpa


Malaysian Reserve
5 days ago
- Malaysian Reserve
Manulife Survey Reveals Hongkongers' New Perspective on Longevity-Prioritizing Living Well on Their Own Terms Over Simply Living Longer
77%[1] of respondents define health as 'living independently and doing what's important', prioritizing a meaningful life over simply living longer. Many would prefer a fulfilling life to age 75 over living to 80 in an ordinary manner—reflecting a shift in how longevity is traditionally perceived. Resilience across physical, financial, and mental well-being—alongside strong family support—is key to aging well. With health issues to emerge as early as age 39 on average among respondents, the three most anticipated areas of increased spending are medication (43%), major illnesses and surgeries (37%), and mobility support (35%). To sustain themselves in later years, 91% are open to lifestyle changes such as cutting utility bills, choosing more affordable meals, or seeking cross-border healthcare. Mental health and family relationships are also seen as vital, with 83% valuing family support for mental well-being and 77% linking mental health to longevity. Building steady income streams and seeking financial professional advice are seen as key to sustaining one's desired lifestyle in retirement. 43% of respondents expect their pension providers to help ensure stable income in retirement, while many don't recognize the importance of diversifying their investments. HONG KONG, July 17, 2025 /PRNewswire/ — The latest findings from the Manulife Asia Care Survey 2025 offer new insights into how Hongkongers perceive longevity. Rather than simply aspiring to live longer or avoid illness, the majority of the respondents now prioritize leading a fulfilling life on their own terms—valuing independence, purpose, and meaningful experiences. As this broader understanding of longevity takes hold, there is an urgent need for proactive planning and professional support. These measures can empower individuals to make informed decisions and adopt behaviours that foster holistic health and financial security, ultimately helping them achieve their life goals. New Perspective on Longevity: Balancing Life Quality and Lifespan According to the Hong Kong version of this survey, conducted between January and February 2025 with 1,000 adults aged 25 or above in Hong Kong, 77% of respondents define health as 'living independently and doing what's important', rather than merely avoiding illness. Many indicated they would prefer a more fulfilling life—even if it meant living to age 75 instead of the average 80—highlighting a growing appreciation for life satisfaction alongside longevity. When asked about their top aspirations: 47% prioritize maintaining their physical and mental well-being to age gracefully. 41% aim for total financial independence and freedom. 33% focus on achieving or maintaining their most desired lifestyle or quality of life. 'It's encouraging to see more people in Hong Kong redefining what it means to live well—not just living longer, but living with purpose, independence, and peace of mind,' said Celia Ling, Chief Marketing Officer, Manulife Hong Kong and Macau. 'At Manulife, we recognize that quality and quantity of life don't have to be a trade-off. As people navigate their lifestyles and financial choices, the demand for flexibility and support continues to grow. Through our holistic suite of insurance products and services—designed to provide protection during illness and help financial planning for the future—we empower our customers to embrace aging with greater resilience and treat it as an evolving journey.' The Three Pillars of Resilience: Physical, Financial, and Mental Well-being—Strengthened by Family Ties As individuals increasingly prioritize a fulfilling life over simply living longer, the survey reveals that achieving this vision requires resilience across three key pillars: physical, financial, and mental well-being—supported by the vital role of family relationships. Respondents report experiencing signs of health issues as early as age 39 on average, despite expecting them to begin around 67. Among them: 43% expect higher spending on medication. 37% foresee increased costs for major illnesses or surgeries. 35% anticipate greater expenses due to declining mobility or disability. In response, 91% are willing to make lifestyle adjustments to manage financial pressures during extended retirement, including reducing utility expenses (40%), choosing more affordable meals (30%), or seeking medical treatment across the border (20%). Beyond physical and financial health, mental well-being and family support also play a critical role. 83% believe family relationships are as important as financial well-being in supporting mental health, while 77% believe mental well-being significantly affects longevity. These findings underscore the importance of building all-rounded resilience early on—by maintaining a balanced focus on physical health, financial security, and mental well-being, while also nurturing strong family ties. They further highlight the value of adequate protection, with 61% of respondents agreeing that having insurance can influence their ability to sustain physical health. Seeking Steady Income in Retirement while Overlooking Diversification With growing awareness of the link between financial health and longevity, the survey shows that building long-term income streams is essential for achieving a desired lifestyle in retirement. 43% of respondents look to pension providers for services that ensure steady income, while 36% prioritize long-term investment growth and 32% seek protection against inflation. While the majority (70%) view financial health as a key enabler of longevity, 52% of respondents feel they may not have sufficient funds for retirement. The mindset that 'cash is king' is prevalent among most people. Cash makes up 45% of liquid assets (property excluded) across total savings and investments, with younger individuals aged 25-34 holding an even larger share at 53%. When it comes to retirement preparation, 55% still consider cash their most important asset, followed by pension schemes (31%). Jeanie Ho, Head of Hong Kong and Macau Retirement, Manulife, commented: 'While cash offers a sense of security, it alone is oftentimes insufficient in maintaining a high quality of life in retirement. Our survey shows that as the MPF system continues to mature, MPF schemes are playing an increasingly important role in retirement financial planning. At Manulife, we are committed to driving product innovation in the MPF space. In addition to offering the widest range of fund choices in the market, we are also strengthening investor education through artificial intelligence (AI) in creating educational videos and an MPF simulation game platform. These efforts aim to foster awareness and habits around continued investing after retirement, helping Hongkongers achieve their desired lifestyle throughout longer lives.' The Role of Professional Guidance in Achieving Longevity Goals With longer life expectancy adding complexity to retirement planning, the survey emphasizes the critical role of professional guidance. Among respondents, 62% of those who have a professional financial planner are confident in having sufficient funds for retirement, compared to just 29% of those without one. However, the necessity for diversification is not top of mind, with only 30% actively prioritizing it. This may hinder their ability to build sustainable wealth for retirement and effectively mitigate inflationary risks. By aligning professional advice with the evolving goals of today's retirees—who seek not just longer lives, but better ones—financial planners can play a transformative role in helping Hongkongers age with confidence, resilience, and purpose. For further details on the Hong Kong-specific findings of the Manulife Asia Care Survey 2025, please visit: About the Manulife Asia Care Survey The Asia Care Survey 2025 was conducted across January and February 2025 and captured insights from over 9,000 individuals aged 25 or above (including 60+) across nine Asian markets: Mainland China, Hong Kong SAR, Taiwan region, Japan, Singapore, Vietnam, Indonesia, Philippines, and Malaysia. About Manulife Hong Kong Manulife Hong Kong has been a trusted name for more than 125 years. Since our operations started in Asia in 1897, we have grown to become one of the top-tier providers of financial services, offering a diverse range of protection and wealth products and services to over 2.6 million customers in Hong Kong and Macau. We are committed to helping make decisions easier and lives better for our customers. Manulife Hong Kong, through Manulife International Holdings Limited, owns Manulife (International) Limited, Manulife Investment Management (Hong Kong) Limited, and Manulife Provident Funds Trust Company Limited. These entities are all subsidiaries of Manulife Financial Corporation. About Manulife Manulife Financial Corporation is a leading international financial services provider, helping our customers make their decisions easier and lives better. With our global headquarters in Toronto, Canada, we operate as Manulife across Canada, Asia, and Europe, and primarily as John Hancock in the United States, providing financial advice and insurance for individuals, groups and businesses. Through Manulife Wealth & Asset Management, we offer global investment, financial advice, and retirement plan services to individuals, institutions, and retirement plan members worldwide. At the end of 2024, we had more than 37,000 employees, over 109,000 agents, and thousands of distribution partners, serving over 36 million customers. We trade as 'MFC' on the Toronto, New York, and the Philippine stock exchanges, and under '945' in Hong Kong. Not all offerings are available in all jurisdictions. For additional information, please visit [1] Some figures in this press release are rounded to the nearest whole number for ease of presentation, while others reflect exact values as reported in the survey.


The Star
5 days ago
- The Star
Long Covid: Probiotics could form a potential treatment
There is no single treatment option for those with post-acute Covid-19 syndrome or long Covid, which remains a serious, but poorly-addressed public health concern worldwide. Globally, it is estimated to have affected some 400 million individuals who experience lingering symptoms such as brain fog, digestive issues and general malaise. In an attempt to find a solution, a team of researchers from the Chinese University of Hong Kong (CUHK) decided to assess a symbiotic preparation (a formulation that combines probiotics and prebiotics) to see if it could alleviate long Covid symptoms. This is as previous CUHK studies had shown that long Covid patients had altered gut microbiomes. Their formulation was developed based on a decade of research on Asian gut microbiomes. It consists of three probiotics ( Bifidobacterium adolescentis , Bifidobacterium longum and Bifidobacterium bifidum ) and three prebiotic fibres (galactooligosaccharides, xylooligosaccharides and resistant dextrin). From 2021 to 2022, 463 recovered patients with at least one long Covid symptom were recruited for the randomised controlled trial in Hong Kong. Nearly 70% were suspected to have been infected with the SARS-CoV-2 Omicron variant. The patients were randomly assigned to receive either the formulation or a placebo containing low dose Vitamin C for six months. At the end of the study, 70% of the former reported improvement in digestive problems, compared to 54.1% in the placebo group. The group taking the formulation also had more improvements for symptoms like fatigue, difficulty in concentration, memory loss and general unwellness, compared to those taking the placebo. Analysis of their stool also showed that the formulation resulted in increased bacteria diversity, increased abundance of 'favourable' bacteria, and reduced abundance of 'unfavourable' bacteria in the gut. 'To our knowledge, this is the first clinical trial to show that modulation of the gut microbiome can improve long Covid symptoms, including memory and concentration problems. 'These data support the importance of the gut-brain axis. 'Restoring a healthy gut microbiota is a novel approach to improve neurological symptoms via the production of beneficial metabolites from gut bacteria that circulate to the brain to improve brain function,' says study lead investigator and gastroenterologist Professor Dr Siew C. Ng. The groundbreaking research was published in the March 2024 issue of the Lancet Infectious Diseases journal. 'We've seen that gut bacteria colonisation takes about six to 12 months to happen, so I tell my patients to take the formulation for a minimum of six months. 'If symptoms improve, they can come off it. 'A small proportion of them can do this, but over time, the bacteria may drop depending on diet, whether you received antibiotics, etc. 'However, a lot of patients are still on it after three years as they reported that once they stopped taking it, some of their symptoms returned. 'There is really no one-size-fits-all approach,' she says in a recent interview. Probiotic supplements are generally taken for health benefits, but if you're already healthy, do you need them? Prof Ng says: 'It's all right to be sceptical of probiotics as there are so many out there that claim to work. 'You're taking them for prevention, but it makes no difference if you're healthy as you won't know if it is working!' The associate dean of CUHK's Faculty of Medicine, who has been doing probiotics research for decades, is on a mission to educate doctors and pharmacists on how to choose or prescribe probiotics. 'Personally, I need scientific back-up to gauge the effectiveness of probiotics. 'We have isolated strains in our laboratory and know that not all of them have equal benefits. 'We've done clinical studies that showed no difference in gut microbiota when you take some of them. 'My advice to the public is to first try lifestyle measures to modulate the gut before taking probiotics. 'Then look at the large clinical studies and digest the information before deciding if you really need these supplements,' she says, adding that their formulation is now available in selected pharmacies in Malaysia. Click here for more on CUHK's research on restoring the gut microbiota to address eczema in children.